Pricing Log in Create free account

AbCellera Biologics Inc. (ABCL) vs Iovance Biotherapeutics, Inc. (IOVA)

AbCellera Biologics Inc. and Iovance Biotherapeutics, Inc. are both Biotechnology companies. AbCellera Biologics Inc. and Iovance Biotherapeutics, Inc. are of similar size ($3.6B and $3.5B). AbCellera Biologics Inc. grew revenue faster over the last twelve months: 101.3% against 51.3%. Iovance Biotherapeutics, Inc. has the higher net margin (−58.2% vs −248.8%) and the higher return on invested capital (−17.7% vs −42.5%). Across the 16 metrics below, AbCellera Biologics Inc. leads on 8 and Iovance Biotherapeutics, Inc. on 8.

Valuation

Metric ABCL IOVA Biotechnology median
P/E n/m n/m 10.26
P/S 51.95 9.29 9.18
P/B 3.84 4.33 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 43.46 8.51 8.98
Earnings yield (4.80%) (6.78%) (34.89%)
Free cash flow yield (3.57%) (6.14%) (24.52%)

Profitability

Metric ABCL IOVA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (340.25%) (60.79%) 0.00%
Net margin (248.82%) (58.19%) 0.00%
Free cash flow margin (180.84%) (57.01%) 0.00%
Return on equity (17.30%) (29.11%) (50.12%)
Return on assets (12.15%) (23.26%) (45.60%)
Return on invested capital (42.52%) (17.72%) 0.00%

Growth

Metric ABCL IOVA Biotechnology median
Revenue growth (TTM) 101.29% 51.34% 6.26%
EPS growth (last fiscal year) 10.91% 14.84% 29.88%
Revenue growth, 5-year CAGR (20.27%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABCL IOVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.77 5.20 4.89
Net debt to EBITDA 2.97 0.82 1.01

Dividend

Metric ABCL IOVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABCL IOVA Biotechnology median
Market cap 3.61b 3.51b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack